J&J Remicade "Dear Doctor" Letter Warns Of Hepatotoxicity Risk
This article was originally published in The Pink Sheet Daily
Executive Summary
Remicade label adds warnings on hepatotoxicity and risk of infections relating to pneumonia based on post-marketing reports. FDA approves new indication for the TNF-inhibitor for treatment of ankylosing spondylitis.